1920x400Cab 3Reunion

Structural atrial disease

Jueves, 2 de Marzo de 17:30h a 19:00h en Auditorio


Dr. Francisco García-Cosío Mir
Doctor en Medicina por la Universidad Complutense de Madrid. Jefe de Servicio de Cardiología del Hospital Universitario de Getafe hasta diciembre de 2013. Fellow Emérito del American College of Cardiology, European Society of Cardiology y Heart Rhythm Society. Distinguished Teacher Award de la Heart Rhythm Society (HRS), Mayo 2005. Eintoven Lecture Award de la European Heart Rhythm Association (EHRA), Junio 2011. Catedrático Emérito de Cardiología, Universidad Europea de Madrid.
Dr. José M. Guerra Ramos
Especialidad de Cardiología y un año de Arritmias en el Hospital Vall d’Hebron, Barcelona. "Fellow" clínico y de investigación en arritmias en el Krannert Institute of Cardiology, Indianapolis, y en la University of California San Francisco. Unidad de Arritmias del Hospital de la Santa Creu i Sant Pau de Barcelona. Twitter: @JoseMGuerraR


Low-voltage areas in patients with AF: prevalence, significance and potential target for ablation

Dr. Thomas Arentz
Dr. Thomas Arentz was born in Köln in 1961. After completing his medical studies between Köln and Clermont-Ferrand, he obtained his MD degree in 1987 in the University of Köln, and completed his specialization in Internal Medicine (1993) and Cardiology (1998). In 1996, he undertook his personal adventure in the field of heart rhythm diseases in the EP Department of the Herz-Zentrum Bad Krozingen, where he has performed over 3000 ablation procedures and is now the Clinical Head. There, he nourishes regular collaborations with several European EP departments, particularly with the Bordeaux group around Michel Haissaguerre and the RETAC Group, from which he is a founding member. He has also taken part in several multicentric studies and lead himself clinical research. Since 1998, he has concentrated in atrial fibrillation catheter ablation. During the last years, has published over 50 original articles in international journals, with a working concept centered in the understanding of the mechanisms of cardiac arrhythmias and the practice of evidence-based medicine, while keeping a high safety degree

Pulmonary vein isolation (PVI) is an effective treatment in 70% of patients with paroxysmal and in 50% in persistent atrial fibrillation (AF)

Localized sources of AF can be identified by high density mapping in low voltage areas with distinct electrical activation characteristics

Ablation of those areas in addition to PVI is more effective than conventional PVI-only strategy for persistent AF

Atrial cardiomyopathies

Dr. Andreas Goette
Department of Cardiology and Intensive Care Medicine, St Vincenz Hospital, Germany

Magnetic resonance imaging of atrial fibrosis: feasibility, limitations and relevance to AF ablation strategies and results

Dr. Nassir Marrouche
University Hospital. Cardiovascular Center. Salt Lake City, Utha (EE UU). Twitter: @nmarrouche